MA52938A - Composés inhibiteurs d'oga - Google Patents

Composés inhibiteurs d'oga

Info

Publication number
MA52938A
MA52938A MA052938A MA52938A MA52938A MA 52938 A MA52938 A MA 52938A MA 052938 A MA052938 A MA 052938A MA 52938 A MA52938 A MA 52938A MA 52938 A MA52938 A MA 52938A
Authority
MA
Morocco
Prior art keywords
inhibitor compounds
oga inhibitor
oga
compounds
inhibitor
Prior art date
Application number
MA052938A
Other languages
English (en)
Inventor
José Manuel Bartolomé-Nebreda
Lucas Olivares Ana Isabel De
Francisca Delgado-Jiménez
Andrés Avelino Trabanco-Suárez
Ramiro Juan Antonio Vega
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52938A publication Critical patent/MA52938A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA052938A 2018-06-20 2019-06-20 Composés inhibiteurs d'oga MA52938A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382450 2018-06-20

Publications (1)

Publication Number Publication Date
MA52938A true MA52938A (fr) 2021-04-28

Family

ID=62784077

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052938A MA52938A (fr) 2018-06-20 2019-06-20 Composés inhibiteurs d'oga

Country Status (8)

Country Link
US (1) US20210300900A1 (fr)
EP (1) EP3810595A1 (fr)
JP (1) JP2021528412A (fr)
CN (1) CN112334462A (fr)
AU (1) AU2019291097A1 (fr)
CA (1) CA3102903A1 (fr)
MA (1) MA52938A (fr)
WO (1) WO2019243531A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA47591A (fr) * 2017-02-27 2020-01-01 Janssen Pharmaceutica Nv Dérivés de [1,2,4]-triazolo [1,5-a]-pyrimidinyle substitués par de la pipéridine, de la morpholine ou de la pipérazine utilisés en tant qu'inhibiteurs d'oga

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201701315VA (en) * 2014-08-28 2017-03-30 Asceneuron Sa Glycosidase inhibitors
CN108884077A (zh) * 2016-02-25 2018-11-23 阿森纽荣股份公司 糖苷酶抑制剂
US20190152992A1 (en) * 2016-06-29 2019-05-23 Orion Corporation Benzodioxane derivatives and their pharmaceutical use
EP3555087A1 (fr) * 2016-12-16 2019-10-23 Janssen Pharmaceutica NV Composés inhibiteurs d'oga monocyclique

Also Published As

Publication number Publication date
CA3102903A1 (fr) 2019-12-26
AU2019291097A1 (en) 2020-12-17
JP2021528412A (ja) 2021-10-21
CN112334462A (zh) 2021-02-05
WO2019243531A1 (fr) 2019-12-26
US20210300900A1 (en) 2021-09-30
EP3810595A1 (fr) 2021-04-28

Similar Documents

Publication Publication Date Title
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
MA47575A (fr) Composés inhibiteurs d'oga monocyclique
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
MA47420A (fr) Composés inhibiteurs d'oga
MA52489A (fr) Nouveaux composés
MA44725A (fr) Formulations d'un inhibiteur de lsd1
MA52967A (fr) Composés antagonistes du pcsk9
MA51669A (fr) Composés
MA51616A (fr) Inhibiteurs d'adn-pk
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
UA42295S (uk) Комп'ютер
MA46652A (fr) Polythérapie pour l'inhibition de c3
MA46242A (fr) Composés inhibiteurs de bêta-lactamase
ES2972949T3 (es) Compuestos de azolamida plaguicidamente activos
MA54521A (fr) Dérivés d'oxopyridine substitués
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
UA42369S (uk) Комп'ютер
MA49006A (fr) Inhibiteurs d'ip6k
DK3737677T3 (da) Tetrahydroisoquinolinforbindelser
MA52946A (fr) Composés
MA53430A (fr) Nouveaux composés
MA52937A (fr) Composés inhibiteurs d'oga
MA52936A (fr) Composés inhibiteurs d'oga